Elite Pharmaceutical

ELTP
Delayed OTC Bulletin Board - Other OTC - 05/17 09:49:35 pm
0.084USD
+1.57%
Prev.0.0827
Open0.0780
High0.0850
Low0.0780
Volume311 850
Company
Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is principally engaged in the development and manufacture of oral, controlled-release products. The Company develops and manufactures generic products, products using controlled-release drug technology, products...
Sector :
Bio Therapeutic Drugs
Calendar :
2019-06-12 Earnings Release
Latest news
03/12ELITE PHARMACEUTICALS : Enters into Strategic Marketing Alliance with Lannett for Generic Adderall
AQ
03/12LANNETT : Enters Into Distribution Agreement for Generic Adderall
AQ
03/11ELITE PHARMACEUTICALS INC /NV/ : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
02/12ELITE PHARMACEUTICALS INC /NV/ : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
02/11Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2019 Ended December 31, 2018 and Provides Conference Call Information
GL
02/11ELITE PHARMACEUTICALS // MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (FORM 10 Q : ELITE PHARMACEUTICALS INC /NV/ MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
02/07ELITE PHARMACEUTICALS : to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2019 Financial Results on February 12, 2019
AQ
01/04ELITE PHARMACEUTICALS : and SunGen Pharma File ANDA for an Antibiotic
AQ